In the British pharmaceutical industry, there were 30 M&A deals announced in Q3 2024, worth a total value of $1.8bn, according to GlobalData’s Deals Database. The $635.2m acquisition of NorthWest Healthcare Properties Real Estate Investment Trust by Assura was the industry’s largest disclosed deal. GlobalData’s Pharmaceuticals Industry Mergers and Acquisitions Deals by Top Themes report for Q3 2024 dissects the driving forces behind the M&A dynamics within the Pharma sector, offering essential insights into industry trends and transformations. Buy the report here.
In value terms, M&A activity in the UK decreased by 53% in Q3 2024 compared with the previous quarter’s total of $3.8bn and fell by 79% as compared to Q3 2023. Related deal volume increased by 58% in Q3 2024 versus the previous quarter.
The top-ranked financial advisors supporting these M&A deals in the UK in 9M 2024 were Rothschild & Co; BDO International; Cavendish Financial with 3, 2, 2 deals respectively.
The top-ranked legal advisors supporting these M&A deals in the UK in 9M 2024 were Addleshaw Goddard; Hill Dickinson; Stevens & Bolton with 3, 2, 2 deals respectively.
For further understanding of GlobalData's Pharmaceuticals Industry M&A Deals by Top Themes in Q3 2024 – Strategic Intelligence, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.